Abstract
Hyperthermic intraperitoneal chemotherapy (HIPEC) was first delivered to a human in 1979 by Dr. John Spratt at the University of Louisville when he treated a male patient with pseudomyxoma peritonei (1). In collaboration with other researchers, he developed a delivery system using a “closed” technique, with both the fascia and skin closed.
Since that time, there has been increasing interest around the world in the delivery of HIPEC. The most widely used methods have involved perioperative perfusion of chemotherapy in heated perfusate performed at the time of open laparotomy (see the following sections), but delivery of HIPEC has also been reported with laparoscopic placement of inflow and outflow tubing (2) and regional (3) and whole-body hyperthermia (4).
Hyperthermic intraperitoneal chemotherapy requires an organized team within the operating room who all understand their roles. The anesthesiologist manages the cooling of the patient’s core temperature before the hyperthermic perfusion and monitors the patient’s vital parameters, particularly the core temperature, during the perfusion. The perfusionist, often recruited from cardiac surgery because of experience with the techniques of cardiopulmonary bypass, operates the heat exchange pump and equipment for the perfusion. Although it is everyone’s responsibility, the scrub technicians and circulating nurses are charged with the specific duty of ensuring proper adherence to operating room protocol for the use of hazardous agents.
The two main techniques for hyperthermic IP perfusion are “open,” where the incision is open during the HIPEC, and “closed” where the abdominal skin and/or fascia are closed. Both basic methods have been extensively utilized, with many individual variations. In this chapter, the most widely used open technique, the “Coliseum,” and the closed technique will be described and discusse
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Spratt JS, Adcock RA, Muskovin M, et al. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40(2):256–260.
Chang E, Alexander HR, Libutti SK, et al. Laparoscopic continuous hyperthermic peritoneal perfusion. J Am Coll Surg 2001;193(2):225–229.
Leopold KA, Oleson JR, Clarke-Pearson D, et al. Intraperitoneal cisplatin and regional hyperthermia for ovarian carcinoma. Int J Radiat Oncol Biol Phys 1993;27(5):1245–1251.
Robins HI, Cohen JD, Schmitt CL, et al. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients. J Clin Oncol 1993;11:1787–1794.
Sugarbaker PH. Management of Peritoneal Surface Malignancy. Preface. Surg Oncol Clin N Am 2003;12(3):xxi–xxiv.
Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy and perioperative intraperitoneal chemotherapy: The evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 2003;21:233–248.
Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6(8):790–796.
Fujimura T, Yonemura Y, Fushida S, et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65(1):65–71.
Yamagushi A, Tsukioka Y, Fushida S, et al. Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers. Dis Colon Rectum 1992;35(10):964–968.
Yonemura Y, Ninomiya I, Kaji M, et al. Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg 1995;19(3):450–454.
Yoshida Y, Sasaki H, Kurokawa T, et al. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up. Oncol Rep 2005;13(1):121–125.
Ryu KS, Kim JH, Ko HS, et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004;94(2):325–332.
Elias D, Antoun S, Goharin A, et al. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Invest 2000;1(5):431–439.
Loggie BW, Sterchi JM, Rogers AT, et al. Intraperitoneal hyperthermic chemotherapy for advanced gastrointestinal and ovarian cancers. Reg Cancer Treat 1994;2:78–81.
Bartlett DL, Buell JF, Libutti SK, et al. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis [erratum appears in Cancer 1998;83(10):2241]. Cancer 1998;83(6):1251–1261.
Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997;79(5):884–891.
Steller MA, Egorin MJ, Trimble EL, et al. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer [erratum appears in Cancer Chemother Pharmacol 1999;44(1):90]. Cancer Chemother Pharmacol 1999;43(2):106–114.
Deraco M, Rossi CR, Pennacchioli E, et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: A phase II clinical study. Tumori 2001;87:120–126.
de Bree E, Romanos J, Michalakis J, et al. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 2003;23(3C):3019–3027.
Ahmad SA, Sussman JJ, Kim J, et al. Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2003;10:574.
Sayag-Beaujard AC, Francois Y, Glehen O, et al. Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination intraperitoneal hyperthermia and mitomycin C. Bulletin du Cancer 2004;91(5):113–132.
Zanon C, Clara R, Chiappino I, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 2004;28(10):1040–1045.
Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999;6(8):790–796.
Shimizu T, Maeta M, Koga S. Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Brit J Surg 1991;78(1):57–59.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Esquivel, J., Sugarbaker, P.H., Helm, C.W. (2007). Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy. In: Helm, C.W., Edwards, R.P. (eds) Intraperitoneal Cancer Therapy. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-195-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-195-6_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-878-2
Online ISBN: 978-1-59745-195-6
eBook Packages: MedicineMedicine (R0)